| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Accounting Officer | 101 | $2.01 | $203 | 18,033 | Aug 18, 2026 | Aug 20, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 14,227 | — | — | 18,134 | May 18, 2026 | May 20, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Accounting Officer | 99 | $1.92 | $190 | 3,907 | May 14, 2026 | May 18, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 31,900 | — | — | 31,900 | Mar 1, 2026 | Mar 3, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Accounting Officer | 116 | $1.63 | $189 | 4,006 | Feb 14, 2026 | Feb 18, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Accounting Officer | 99 | $2.24 | $222 | 4,122 | Nov 14, 2025 | Nov 18, 2025 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Accounting Officer | 99 | $1.39 | $138 | 4,221 | Aug 14, 2025 | Aug 18, 2025 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Accounting Officer | 99 | $1.14 | $113 | 4,320 | May 14, 2025 | May 16, 2025 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 31,900 | — | — | 31,900 | Mar 1, 2025 | Mar 4, 2025 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Accounting Officer | 116 | $5.42 | $629 | 4,419 | Feb 14, 2025 | Feb 19, 2025 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Accounting Officer | 99 | $7.92 | $784 | 4,535 | Nov 14, 2024 | Nov 18, 2024 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Accounting Officer | 99 | $7.02 | $695 | 4,634 | Aug 14, 2024 | Aug 16, 2024 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Accounting Officer | 99 | $8.36 | $828 | 4,733 | May 14, 2024 | May 16, 2024 ↗ | View → |